Leading Russian drugmakers call for additional preferences for public procurements

Leading domestic drugmakers in Russia have called on the national government to introduce additional restrictions on the participation of foreign companies in public procurements in the country, reports The Pharma Letter’s Russia correspondent. Local producers believe this should help to further reduce drug imports to Russia.

According to them, despite all the efforts which have been made by the Russian government in recent years, the share of imports in the domestic pharmaceutical market still remains high and continues to grow.

In this regard, Russian drugmakers believe additional restrictions on the participation of global drugmakers in public procurements in Russia should be introduced.